US Broker Ratings

Rigel Pharmaceuticals, Inc. (RIGL)

⚠️ No article content returned.

..

Porch Group, Inc. (PRCH) Stock Analysis: Strong Buy Ratings Drive Investor Optimism Amidst 3.65% Upside Potential

Porch Group, Inc. (NASDAQ: PRCH), a burgeoning player in the technology sector, has captured the attention of investors with its impressive market cap of $1.89 billion. Specializing in software applications,..

Sanara MedTech Inc. (SMTI) Growth Potential: A 46% Upside Awaits in the Healthcare Sector

Sanara MedTech Inc. (SMTI), a prominent player in the healthcare sector specializing in medical instruments and supplies, is drawing attention from investors with its impressive growth metrics and future potential...

AMTD Digital Inc. (HKD): Navigating Challenges and Opportunities in the Tech Sector

AMTD Digital Inc. (NYSE: HKD), a Paris-based technology company, is carving out a unique niche within the software application industry. With a market capitalization of $575.13 million, the company offers..

Quhuo Limited (QH) Stock Analysis: Navigating the Challenges in the Gig Economy Sector

Quhuo Limited (NASDAQ: QH) stands as a notable player within the technology sector, specifically catering to the gig economy through its operations in the software application industry. Based in Beijing,..

Nerdy Inc. (NRDY) Investor Outlook: Unpacking a 60.76% Potential Upside

Nerdy Inc. (NYSE: NRDY), a key player in the technology sector specializing in software applications, presents a compelling case for investors looking at its current valuation and future potential. As..

SANUWAVE Health, Inc. (SNWV) Stock Analysis: A Promising 55.24% Upside in the Medical Device Sector

In the competitive landscape of regenerative medicine, SANUWAVE Health, Inc. (NASDAQ: SNWV) is carving a niche with its innovative medical devices. As a healthcare entity headquartered in Eden Prairie, Minnesota,..

Benitec Biopharma Inc. (BNTC) Investor Outlook: Analyzing the 81% Potential Upside in Biotechnology

Benitec Biopharma Inc. (NASDAQ: BNTC) has been making waves in the biotechnology sector with its promising pipeline of novel genetic medicines. This clinical-stage company, headquartered in Hayward, California, is focused..

Alumis Inc. (ALMS) Stock Analysis: A Biotech with a Potential 360% Upside

Alumis Inc. (NASDAQ: ALMS), a burgeoning name in the biotechnology sector, is attracting significant attention from investors, primarily due to its promising pipeline in autoimmune disorders and a staggering potential..

Tvardi Therapeutics, Inc. (TVRD) Stock Analysis: A Biotech with a 46% Upside Potential

Tvardi Therapeutics, Inc. (TVRD), a promising entity in the biotechnology sector, is capturing the interest of investors with its focus on developing innovative therapies targeting STAT3 to address fibrosis-driven diseases...

CytomX Therapeutics, Inc. (CTMX) Stock Analysis: Exploring a Potential 197.93% Upside in Biotechnology

CytomX Therapeutics, Inc. (NASDAQ: CTMX) is drawing attention from investors with an impressive potential upside of nearly 198%, as suggested by its average target price of $5.75. This California-based biopharmaceutical..

Viemed Healthcare, Inc. (VMD) Stock Analysis: A Potential 99% Upside in the Medical Device Sector

Viemed Healthcare, Inc. (VMD), a key player in the medical devices sector, presents a compelling investment opportunity with a remarkable potential upside of 99.39%. This Louisiana-based company, with a market..

Gossamer Bio, Inc. (GOSS) Stock Analysis: Exploring a Potential 196% Upside in the Biotech Sector

Gossamer Bio, Inc. (NASDAQ: GOSS) is making waves in the biotechnology industry with a staggering potential upside of 196.23%, according to recent analyst ratings. As a clinical-stage biopharmaceutical company, Gossamer..

Cartesian Therapeutics, Inc. (RNAC) Stock Report: Unpacking a 298% Potential Upside in Biotechnology

Investors with an appetite for innovation in the healthcare sector might find Cartesian Therapeutics, Inc. (RNAC) an intriguing prospect. The clinical-stage biotechnology company, headquartered in Frederick, Maryland, is pioneering mRNA..

Cytek Biosciences, Inc. (CTKB) Stock Analysis: Unpacking a 30.74% Potential Upside for Investors

Investors with an interest in the healthcare sector, specifically within the medical devices industry, may find Cytek Biosciences, Inc. (NASDAQ: CTKB) an intriguing opportunity. This Fremont, California-based company is renowned..

Cidara Therapeutics (CDTX) Stock Analysis: Exploring a 23% Potential Upside in the Biotech Arena

For investors with an eye on the biotechnology sector, Cidara Therapeutics, Inc. (NASDAQ: CDTX) presents an intriguing opportunity. Specializing in targeted therapies for critical diseases such as cancer and invasive..

Chevron Corporation (CVX) Investor Outlook: Analyzing a 4.27% Dividend Yield Amidst Market Dynamics

Chevron Corporation (NYSE: CVX) stands tall in the energy sector as one of the world’s leading oil and gas integrated companies. With a robust market capitalization of $322.55 billion, Chevron..

aTyr Pharma, Inc. (ATYR) Stock Analysis: Navigating a Potential 393.90% Upside in Biotech

Investors with an appetite for high-risk, high-reward opportunities may want to turn their attention to aTyr Pharma, Inc. (NASDAQ: ATYR), a biotechnology company poised at the cutting edge of fibrosis..

Abeona Therapeutics Inc. (ABEO) Stock Analysis: Eyeing a 263% Upside with Biotech Innovations

Abeona Therapeutics Inc. (NASDAQ: ABEO), a clinical-stage biopharmaceutical company, has captured the attention of investors with a compelling narrative of innovation in the healthcare sector. Specializing in gene and cell..

Aurora Cannabis Inc. (ACB) Stock Analysis: Exploring a 26.99% Upside Potential Amidst Revenue Growth

Aurora Cannabis Inc. (NASDAQ: ACB), a prominent player in the healthcare sector within the specialty and generic drug manufacturing industry, offers intriguing prospects for individual investors keen on the burgeoning..

Search

Funds

US Broker Ratings

Search

Funds

US Broker Ratings

FTSE 100

Funds